Emerging technologies are quickly playing a greater role in how the Pharmaceutical and Life Sciences Industry collects, stores and interprets its data. Mixed Reality platforms are becoming more widespread in the application of displaying and
interrogating this data. This paper summarises the trials of an initiative supported by KENX USA, TU Dublin and BioPharmaChem Ireland (BPCI). One technology platform, in this case the Microsoft HoloLens 2, was trialled in 3 areas of interest for the industry; namely Remote Equipment Qualifications, Remote Audits & Inspections and Remote Factory Acceptance Testing (FAT).